Education Tenders

Pfa Asbestos Dynamic Purchasing System

Conclusion of Non-Exclusive Discount Agreements According to §§ 130A Abs. 8/130C Abs. 1 Sgb V for Drugs with the Active Ingredient Betamethasone and Antibiotics (D07cc01) as Part of an Open House Model.

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A (8) Sgb V for the Active Ingredient Latanoprost (Exclusively Single-Dose Containers), Atc S01ee01 for the Period June 1St, 2023 - May 31St, 2025

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Sultamicillin (J01cr04) as Part of a So-Called Open House Model.

Acquisition of Vehicles

Special Applications Used in Customer and Care Work in the Sote Industry

Conclusion of a Non-Exclusive Discount Agreement in Accordance with § 130A Paragraph 8 Sgb V for the Active Substance Duloxetine (Only Strengths 90 Mg and 120 Mg), Atc N06ax21 for the Period 06/01/2023 - 05/31/2025

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Alirocumab, Atc C10ax14 for the Period June 1St, 2023 - May 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Substance Benralizumab, Atc R03dx10 for the Period June 1St, 2023 - May 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A (8) Sgb V for the Active Substance Latanoprost Timolol (Excluding Single-Dose Containers), Atc S01ed61 for the Period June 1St, 2023 - May 31St, 2025